To Explore the Effect of Intracranial Hematoma Minimally Invasive Treatment in the Treatment of Cerebral Hemorrhage
Zhou Xue-ji
Abstract
Zhou Xue-ji
Abstract
Objective To In this paper, the clinical value of intracranial hematoma minimally invasive treatment in the treatment of cerebral hemorrhage were studied and analyzed. Methods 44 patients with cerebral hemorrhage were randomly selected from January 2014 to December 2014. All of the patients were divided into the observation group and the control group by lottery. The patients in the control group received routine therapy. While the patients in the observation group received the intracranial hematoma minimally invasive treatment. After the treatment the clinical effect, the incidence of adverse reactions and the quality of life score of the patients in both of the two groups were observed and analyzed. Results The total effective rate of the observation group after treatment was better than that of the control group. The quality of life score of the observation group was better than that of the control group. The incidence of adverse reactions after treatment of patients of observation group was obviously less than that of the control group patients(P0.05). Conclusion The effect of the intracranial hematoma minimally invasive treatment of cerebral hemorrhage is marked. This treatment significantly improve the patient's clinical symptoms, and is worth popularizing in clinical medicine.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To In this paper, the clinical value of intracranial hematoma minimally invasive treatment in the treatment of cerebral hemorrhage were studied and analyzed. Methods 44 patients with cerebral hemorrhage were randomly selected from January 2014 to December 2014. All of the patients were divided into the observation group and the control group by lottery. The patients in the control group received routine therapy. While the patients in the observation group received the intracranial hematoma minimally invasive treatment. After the treatment the clinical effect, the incidence of adverse reactions and the quality of life score of the patients in both of the two groups were observed and analyzed. Results The total effective rate of the observation group after treatment was better than that of the control group. The quality of life score of the observation group was better than that of the control group. The incidence of adverse reactions after treatment of patients of observation group was obviously less than that of the control group patients(P0.05). Conclusion The effect of the intracranial hematoma minimally invasive treatment of cerebral hemorrhage is marked. This treatment significantly improve the patient's clinical symptoms, and is worth popularizing in clinical medicine.
Key concepts: Medicine, Intracranial hematoma, Hematoma, Incidence (geometry), Treatment and control groups, Surgery, Adverse effect, Intracerebral hemorrhage